BNP and NT-proBNP are released from cardiac myocytes in response to increases in wall stress [10], providing robust and independent prognostic value in patients with various cardiovascular diseases such as heart failure and acute coronary syndromes valvular aortic stenosis, and stable coronary artery disease [11]. This evidence concerns the gene NPPB and acute coronary syndrome.